SEARCH

SEARCH BY CITATION

References

  • 1
    Schurgers LJ, Teunissen KJ, Knapen MH, Kwaijtaal M, van Diest R, Appels A, Reutelingsperger CP, Cleutjens JP, Vermeer C. Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler Thromb Vasc Biol 2005; 25: 162933.
  • 2
    Cranenburg EC, Vermeer C, Koos R, Boumans M-L, Hackeng TM, Bouwman F, Kwaijtaal M, Brandenburg V, Ketteler M, Schurgers LJ. The circulating inactive form of matrix Gla protein (ucMGP) as a biomarker for cardiovascular calcification. J Vasc Res 2008; 45: 42736.
  • 3
    Cranenburg ECM, Brandenburg VM, Vermeer C, Stenger M, Mühlenbruch G, Mahnken AH, Gladziwa U, Ketteler M, Schurgers LJ. Uncarboxylated matrix Gla protein (ucMGP) is associated with coronary artery calcification in haemodialysis patients. Thromb Haemost 2009; 101: 35966.
  • 4
    Price PA, Faus SA, Williamson MK. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 1998; 18: 14007.
  • 5
    Price PA, Roublick AM, Williamson MK. Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate. Kidney Int 2006; 70: 157783.
  • 6
    Wallin R, Cain D, Hutson SM, Sane DC, Loeser R. Modulation of the binding of matrix Gla protein (MGP) to bone morphogenetic protein-2 (BMP-2). Thromb Haemost 2000; 84: 103944.
  • 7
    Bostrom K, Tsao D, Shen S, Wang Y, Demer LL. Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells. J Biol Chem 2001; 276: 1404452.
  • 8
    Zebboudj AF, Imura M, Bostrom K. Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2. J Biol Chem 2002; 277: 438894.
  • 9
    Wajih N, Borras T, Xue W, Hutson SM, Wallin R. Processing and transport of matrix gamma-carboxyglutamic acid protein and bone morphogenetic protein-2 in cultured human vascular smooth muscle cells: evidence for an uptake mechanism for serum fetuin. J Biol Chem 2004; 279: 4305260.
  • 10
    Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386: 7881.
  • 11
    El-Maadawy S, Kaartinen MT, Schinke T, Murshed M, Karsenty G, McKee MD. Cartilage formation and calcification in arteries of mice lacking matrix Gla protein. Connect Tissue Res 2003; 44(Suppl 1): 2728.
  • 12
    Munroe PB, Olgunturk RO, Fryns JP, van Maldergem L, Ziereisen F, Yuksel B, Gardiner RM, Chung E. Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat Genet 1999; 21: 1424.
  • 13
    Keutel J, Jorgensen G, Gabriel P. A new autosomal-recessive hereditary syndrome. Multiple peripheral pulmonary stenosis, brachytelephalangia, inner-ear deafness, ossification or calcification of cartilages. Dtsch Med Wochenschr 1971; 96: 167681.
  • 14
    Say B, Balci S, Pirnar T, Israel R, Atasu M. Unusual calcium deposition in cartilage associated with short stature and peculiar facial features: a case report. Pediatr Radiol 1973; 1: 1279.
  • 15
    Walbaum R, Boniface L, Tonnel AB, Desaulty A, Decroix G. Proceedings: Keutel’s syndrome. Pediatrie 1975; 30: 31314.
  • 16
    Fryns JP, van Fleteren A, Mattelaer P, van den Berghe H. Calcification of cartilages, brachytelephalangy and peripheral pulmonary stenosis. Confirmation of the Keutel syndrome. Eur J Pediatr 1984; 142: 2013.
  • 17
    Cormode EJ, Dawson M, Lowry RB. Keutel syndrome: clinical report and literature review. Am J Med Genet 1986; 24: 28994.
  • 18
    Khosroshahi HE, Uluoglu O, Olgunturk R, Basaklar C. Keutel syndrome: a report of four cases. Eur J Pediatr 1989; 149: 18891.
  • 19
    Ziereisen F, De Munter C, Perlmutter N. The Keutel syndrome. Report of a case and review of the literature. Pediatr Radiol 1993; 23: 31415.
  • 20
    Haddad MC, Sharif HS, Jared MS, Sammak BM, al Shahed MS. Premature tracheobronchial, laryngeal and costochondral cartilage calcification in children. Clin Radiol 1993; 47: 525.
  • 21
    Buchsteiner I, Kempf HG, Arslan-Kirchner M, Schulze-Florey T. Congenital subglottic laryngeal stenosis in 2 brothers with chondrodysplasia syndrome (Keutel–Gabriel syndrome). Laryngorhinootologie 1998; 77: 3636.
  • 22
    Teebi AS, Lambert DM, Kaye GM, Al-Fifi S, Tewfik TL, Azouz EM. Keutel syndrome: further characterization and review. Am J Med Genet 1998; 78: 1827.
  • 23
    Tuysuz B, Ungur S, Akalin F, Cenani A, Tunnessen WW Jr. Picture of the month. Keutel syndrome. Arch Pediatr Adolesc Med 1999; 153: 7656.
  • 24
    Gilbert B, Lacombe D. Keutel syndrome and miscarriages. Am J Med Genet 1999; 83: 20911.
  • 25
    Miller SF. Brachytelephalangy with sparing of the fifth distal phalanx: a feature highly suggestive of Keutel syndrome. Pediatr Radiol 2003; 33: 1869.
  • 26
    Hur DJ, Raymond GV, Kahler SG, Riegert-Johnson DL, Cohen BA, Boyadjiev SA. A novel MGP mutation in a consanguineous family: review of the clinical and molecular characteristics of Keutel syndrome. Am J Med Genet A 2005; 135: 3640.
  • 27
    Parmar H, Blaser S, Unger S, Yoo SJ, Papsin B. Petrified ears in a patient with Keutel syndrome: temporal bone CT findings. Pediatr Radiol 2006; 36: 2413.
  • 28
    Ozdemir N, Ersu R, Akalin F, Karadag B, Kut A, Karakoc F, Elcioglu N, Dagli E. Tracheobronchial calcification associated with Keutel syndrome. Turk J Pediatr 2006; 48: 35761.
  • 29
    Meier M, Weng LP, Alexandrakis E, Ruschoff J, Goeckenjan G. Tracheobronchial stenosis in Keutel syndrome. Eur Respir J 2001; 17: 5669.
  • 30
    Schurgers LJ, Teunissen KJ, Knapen MH, Geusens P, van der Heijde D, Kwaijtaal M, van Diest R, Ketteler M, Vermeer C. Characteristics and performance of an immunosorbent assay for human matrix Gla-protein. Clin Chim Acta 2005; 351: 1318.
  • 31
    Cranenburg EC, Koos R, Schurgers LJ, Magdeleyns EJ, Schoonbrood TH, Landewe RB, Brandenburg VM, Bekers O, Vermeer C. Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species. Thromb Haemost 2010; 104: 81122.
  • 32
    Schurgers LJ, Teunissen KJ, Hamulyak K, Knapen MH, Vik H, Vermeer C. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood 2007; 109: 327983.
  • 33
    Al-Qaisi M, Nott DM, King DH, Kaddoura S. Ankle brachial pressure index (ABPI): an update for practitioners. Vasc Health Risk Manag 2009; 5: 83341.
  • 34
    Jourdan C, Wuhl E, Litwin M, Fahr K, Trelewicz J, Jobs K, Schenk JP, Grenda R, Mehls O, Troger J, Schaefer F. Normative values for intima–media thickness and distensibility of large arteries in healthy adolescents. J Hypertens 2005; 23: 170715.
  • 35
    Gericke A, Qin C, Spevak L, Fujimoto Y, Butler WT, Sorensen ES, Boskey AL. Importance of phosphorylation for osteopontin regulation of biomineralization. Calcif Tissue Int 2005; 77: 4554.
  • 36
    Boskey AL, Maresca M, Ullrich W, Doty SB, Butler WT, Prince CW. Osteopontin–hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Miner 1993; 22: 14759.
  • 37
    Hunter GK, Kyle CL, Goldberg HA. Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation. Biochem J 1994; 300(Pt 3): 7238.
  • 38
    Jono S, Peinado C, Giachelli CM. Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J Biol Chem 2000; 275: 20197203.
  • 39
    Steitz SA, Speer MY, McKee MD, Liaw L, Almeida M, Yang H, Giachelli CM. Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol 2002; 161: 203546.
  • 40
    Schurgers LJ, Spronk HMH, Skepper JN, Hackeng TM, Shanahan CM, Vermeer C, Weissberg PL, Proudfoot D. Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. J Thromb Haemost 2007; 5: 250311.
  • 41
    Murshed M, Schinke T, McKee MD, Karsenty G. Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins. J Cell Biol 2004; 165: 62530.
  • 42
    Berkner KL, Runge KW. The physiology of vitamin K nutriture and vitamin K-dependent protein function in atherosclerosis. J Thromb Haemost 2004; 2: 211832.
  • 43
    Nanda A, Anim JT, Al-Gareeb M, Alsaleh QA. Keutel syndrome with overlapping features of cutis laxa: a new variant. Am J Med Genet A 2006; 140: 14879. Author reply 90.
  • 44
    Shroff RC, McNair R, Figg N, Skepper JN, Schurgers L, Gupta A, Hiorns M, Donald AE, Deanfield J, Rees L, Shanahan CM. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 2008; 118: 174857.
  • 45
    Speer M, McKee M, Guldberg R, Liaw L, Yang H-Y, Tung E, Karsenty G, Giachelli C. Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med 2002; 196: 104755.
  • 46
    Kaartinen MT, Murshed M, Karsenty G, McKee MD. Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of matrix Gla protein-deficient mice. J Histochem Cytochem 2007; 55: 37586.